HLA-B*51 and Behçet Disease.

Area of Science:

• Immunogenetics
• Rheumatology
• Inflammatory Disorders

Background:

• Behçet disease (BD) is a multisystem inflammatory disorder with unknown causes.
• Genetic factors significantly contribute to BD development, with HLA-B5/B*51 being the strongest identified genetic risk factor.
• The precise pathogenic role of HLA-B*51 in BD remains unclear.

Purpose of the Study:

• To explore the potential mechanisms underlying the association between HLA-B*51 and Behçet disease.
• To evaluate the current evidence for HLA-B*51 as a diagnostic or prognostic biomarker in BD management.

Main Methods:

• Review of existing genetic and immunological studies on Behçet disease.
• Analysis of the proposed roles of HLA class I-associated functions and HLA-B*51 structural properties.

Main Results:

• The association of HLA-B5/B*51 is the most significant genetic factor for Behçet disease.
• Current data suggest that HLA-B*51 may exert its effects through multiple mechanisms involving HLA class I functions or structural characteristics.
• No conclusive evidence supports HLA-B*51's utility as a diagnostic or prognostic marker for BD.

Conclusions:

• The genetic susceptibility to Behçet disease is multifactorial, with HLA-B*51 being a critical factor.
• Understanding the complex role of HLA-B*51 requires further investigation into its immunological functions and structural attributes.
• Additional clinical and basic research is necessary to determine if HLA-B*51 can be effectively utilized as a biomarker for managing Behçet disease.